On World Cup final day, Louise Serpell explores football’s links to CTE—and how research, safer rules and better awareness could protect future players.
Submit a validated, patient-friendly digital outcome measure for the AD-SMART Alzheimer’s trial. Proposals close 30 August 2026.
The CELIA trial found diranersen reduced tau and showed signs of slowing decline, while separate research linked blood tau with future Alzheimer’s risk.
The fourth and final of AAIC 2026 highlights podcasts brings together Adam Smith, Dr Niying Li, Dr Natasha Anita & Lillian Morgado sharing learning from the day
A blood test measuring p-tau217 may predict Alzheimer’s-related cognitive decline up to a decade before symptoms appear, AAIC 2026 research finds.
The third of our AAIC 2026 podcasts brings together Adam Smith, Abrar AbuHamdia and Cari Randa-Beaulieu discussing the talks and posters they explored.
New data suggest an Alzheimer’s blood test could help primary care doctors diagnose the disease with around 90% accuracy, matching specialists. #AAIC26
Phase 2 LiBBY trial results suggest a THC/CBD combination rapidly and significantly reduces agitation in hospice-eligible people with dementia. #AAIC26
The second of our AAIC 2026 podcasts brings together Adam Smith, Nathania, Dr Arezoo Talebzadeh and Dr Suelyn Koerich, sharing highlights & takeaways
A new $100m global trial will test whether combining lifestyle support with GLP-1 or similar drugs can reduce cognitive decline and dementia risk.
Dementia Researcher
Alzheimer's Association
